01 1AstraZeneca Pharmaceuticals LP
02 1Hetero Drugs Limited
01 1Sodium Zirconium Cyclosilicate
02 1Sodium zirconium cyclosilicate
01 1India
02 1United Kingdom
SODIUM ZIRCONIUM CYCLOSILICATE
NDC Package Code : 0310-2111
Start Marketing Date : 2021-12-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (243kg/243kg)
Marketing Category : BULK INGREDIENT
SODIUM ZIRCONIUM CYCLOSILICATE
NDC Package Code : 65977-0132
Start Marketing Date : 2018-05-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Sodium Zirconium Cyclosilicate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Zirconium Cyclosilicate, including repackagers and relabelers. The FDA regulates Sodium Zirconium Cyclosilicate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Zirconium Cyclosilicate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Zirconium Cyclosilicate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Zirconium Cyclosilicate supplier is an individual or a company that provides Sodium Zirconium Cyclosilicate active pharmaceutical ingredient (API) or Sodium Zirconium Cyclosilicate finished formulations upon request. The Sodium Zirconium Cyclosilicate suppliers may include Sodium Zirconium Cyclosilicate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Zirconium Cyclosilicate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Zirconium Cyclosilicate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Zirconium Cyclosilicate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Zirconium Cyclosilicate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Zirconium Cyclosilicate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Zirconium Cyclosilicate suppliers with NDC on PharmaCompass.
We have 2 companies offering Sodium Zirconium Cyclosilicate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
